San Diego, CA, United States of America

Nilantha Sudath Sirisoma

USPTO Granted Patents = 7 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
7 patents (USPTO):

Sure, here is the article about inventor Nilantha Sudath Sirisoma:

Title: Inventor Spotlight: Nilantha Sudath Sirisoma

Introduction:

Nilantha Sudath Sirisoma, a talented inventor based in San Diego, CA, has made significant contributions to the field of biotechnology with his groundbreaking patents and research.

Latest Patents:

Nilantha Sudath Sirisoma holds 7 patents, with his latest inventions focusing on innovative methods for treating brain cancer. His patented method involves the use of 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis, which have shown promising results in combating abnormal cell growth, particularly in cases of brain cancer.

Career Highlights:

Throughout his career, Nilantha Sudath Sirisoma has worked with esteemed companies such as Cytovia, Inc. and Myrexis, Inc., where he has demonstrated his expertise in developing novel treatment strategies for various clinical conditions. His dedication to advancing the field of biotechnology is evident in his prolific patent portfolio.

Collaborations:

Nilantha Sudath Sirisoma has collaborated with notable coworkers, including Sui Xiong Cai and John A Drewe, who have contributed to the success of his research projects. Their combined efforts have led to the development of cutting-edge therapies that have the potential to revolutionize the treatment of brain cancer and other related conditions.

Conclusion:

In conclusion, Nilantha Sudath Sirisoma's innovative work in the field of biotechnology underscores his commitment to improving patient outcomes through groundbreaking research and patentable inventions. His contributions are expected to have a lasting impact on the medical community and pave the way for future advancements in the treatment of debilitating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…